glp 1 neurodegenerative disease Dr. Kellyann Niotis | In the last couple of years, GLP-1 receptor agonists ( GLP-1 RAs or GLP-1s), best known for treating type 2 diabetes and obesity, have Anti-Inflammatory Effects of GLP-1 Receptor

82,83 Animal studies have demonstrated the protective effects of DPP4 inhibitors in IBD

Every body is different, and any usual side effects or symptoms you notice deserve care from your provider

High Potency Vitamin C

Melanin, which is synthesized by melanocytes and nevus cells, may appear as brown, blue, or black, depending on the amount of melanin and its spatial location within the tissue (i.e., superficial vs

RiskBenefit Perspective Despite theoretical concerns, the clinical reality is clear: GLP-1 therapies produce substantial weight loss Improve glycemic control and cardiometabolic outcomes Reduce cardiovascular risk in multiple studies When evaluating carcinogenicity risk, current evidence suggests: Strong rodent signals exist but may not translate to humans Long-term human data has not confirmed increased thyroid cancer risk Regulatory warnings remain precautionary rather than confirmatory Conclusion The GLP-1 receptor agonist classfrom Liraglutide to next-generation oral agents like Orforglipronrepresents one of the most transformative areas in metabolic medicine